A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 15, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

March 21, 2012

Conditions
Pelvic Pain Associated With Refractory Endometriosis
Interventions
DRUG

BGS649

0.1 mg capsules for oral administration. A total dose of 3 capsules of BGS649 0.1mg will be administered at randomization, week 4, and week 8 at the study site.

DRUG

Placebo

Placebo matching BGS649 will be provided by Novartis as capsules for oral administration. Three capsules of placebo will be administered at randomization, week 4, and week 8 at the study site.

Trial Locations (44)

15445

Ilumina Clinical Associates, Hopwood

23230

VCU Health Systems, MCV, Richmond

23507

Eastern Va Medical School, Norfolk

26905

Greenville Hospital System, Greenville

27103

Lyndhurst Gynecologic Associates, Winston-Salem

28401

New Hanover Medical Research, Wilmington

29407

Medical Research South, Charleston

29572

Magnolia OB/GYN Research Center, Myrtle Beach

30034

Associated Pharmaceutical Research, Decatur

30035

Legacy Obstetrics & Gynecology, Decatur

30274

Minority Clinical Research Center of Atlanta, Riverdale

33136

University of Miami School of Medicine & Clinics, Miami

33324

West Broward OB/GYN Associates, Plantation

33409

Comprehensive Clinical Trials,LLC, West Palm Beach

33437

Zasa Clinical Research, Boynton Beach

33759

Women's Medical Research Group, LLC, Clearwater

36617

University of South Alabama Medical Center, Mobile

43606

Promedica Health System, Toledo

45322

HWC Women's Research Center, Englewood

48034

Wayne State University, Detroit

48604

Saginaw Valley Medical Research Group, LLC, Saginaw

59808

Montana Medical Research, Missoula

60540

The Advanced Gynecologic Surgery Institute, Naperville

61820

Christie Clinic, Champaign

Women's Health Practice Center, Champaign

67207

Heartland Research Associates, LLC, Wichita

67226

Cypress Medical Research Center, LLC, Wichita

68510

Women's Clinic of Lincoln, PC, Lincoln

71270

Green Clinic, LLC, Ruston

72401

Northeast Arkansas Clinic, Jonesboro

75061

Bexar Clinical Trials, Irving

75230

Practice Research Organization, Dallas

77079

Centex Research, Houston

77566

R/D Clinical Research, Inc., Lake Jackson

85032

Precision Trials, Phoenix

87102

Southwest Clinical Research, Albuquerque

98055

Valley Women's Clinic, Renton

06052

Center for Fertility and Women's Health, New Britain

06504

Yale New Haven Hospital, New Haven

02720

NECCR, Fall River

08103

Cooper University Hospital, Camden

08536

Women's Health Research Center, Plainsboro

00917

Henry Rodriguez-Ginorio, MD, San Juan

00716

Ponce School of Medicine, Ponce

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Mereo BioPharma

INDUSTRY

NCT01116440 - A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis | Biotech Hunter | Biotech Hunter